Ipsen
IPN.PA Large CapHealthcare · Drug Manufacturers - Specialty & Generic
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Ipsen Stock at a Glance
Ipsen (IPN.PA) is currently trading at 167,00 € with a market capitalization of 11,7 Mrd. €. The trailing P/E ratio stands at 31.33x, with a forward P/E of 12.4x. The 52-week range spans from 99,00 € to 170,80 €; the current price is 2.2% below the yearly high. Year-over-year revenue growth stands at +9.3%. The net profit margin stands at 11.29%.
💰 Dividendo
Ipsen pays an annual dividend of 1,60 € per share, representing a yield of 0.96%. The payout ratio stands at 26.32%.
📊 Raccomandazioni degli Analisti
16 analysts rate Ipsen (IPN.PA) on consensus: Comprare. The average price target is 155,75 €, implying -6.74% from the current price. Analyst price targets range from 117,00 € to 183,00 €.
Tesi di Investimento: Punti di Forza e Debolezze
- High gross margin of 80.89% — indicates pricing power
- Analyst consensus: Buy
- Solid balance sheet with low debt (D/E 22.38)
- Positive free cash flow
Nessun segnale di allerta significativo nelle metriche attuali.
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior.
Dati di Trading
💵 Info Dividendo
Azioni Correlate nello Stesso Settore
Where can I buy Ipsen?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
